Osivaxt Cell News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Osivaxt Cell. Real-time updates on events, politics, business and more.

Osivax Provides Clinical Development Update on Lead Influenza Vaccine Candidate OVX836

May 25, 2022

Excellent safety continues to be observed in ongoing Phase 2a dose optimization study (OVX836-003) Phase 2a dose optimization study extended to elderly population cohort (OVX836-003)

Kostenloser Wertpapierhandel Desmond James Paul Willems Trophic Communications Vaccinology At Ghent University Osivaxt Cell

Source: finanznachrichten.de

Osivax Enters Research Collaboration with the NIAID for the Evaluation of Combination Approach to Broad-Spectrum Influenza Vaccines

May 17, 2022

Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses and diseases, today announced that it has entered a research

United States Kostenloser Wertpapierhandel Desmond James Vaccine Research Center National Institutes Of Health National Institute Of Allergy

Source: finanznachrichten.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Osivaxt Cell News Today

Osivax Provides Clinical Development Update on Lead Influenza Vaccine Candidate OVX836

Osivax Enters Research Collaboration with the NIAID for the Evaluation of Combination Approach to Broad-Spectrum Influenza Vaccines

Explore More Categories